A series of ferrocene-containing rhodium complexes of the type [Rh(FcCOCHCOR)(cod)] (cod = 1,5-cyclooctadiene) with R = CF3, 1, (Epa(Rh) = 269; Eo′(Fc) = 329 mV vs.Fc/Fc+), CCl3, 2, (Epa = 256; Eo′ = 312 mV), CH3, 3, (Epa = 177; Eo′ = 232 mV), Ph = C6H5, 4, (Epa = 184; Eo′ = 237 mV), and Fc = ferrocenyl = (C5H5)Fe(C5H4), 5, (Epa = 135; Eo′(Fc1) = 203; Eo′(Fc2) = 312 mV), have been studied electrochemically in CH3CN. Results indicated that the rhodium(I) centre is irreversibly oxidised to Rh(III) in a two-electron transfer process before the ferrocenyl fragment is reversibly oxidized in a one-electron transfer process. The peak anodic (oxidation) potential, Epa, (in V vs.Fc/Fc+) of the rhodium core in 1–5 relates to k2, the second-order rate constant for the substitution of (FcCOCHCOR)− with 1,10-phenanthroline in [Rh(FcCOCHCOR)(cod)] to form [Rh(phen)(cod)]+ in methanol at 25 °C with the equation lnk2 = 39.5 Epa(Rh) – 3.69, while the formal oxidation potential of the ferrocenyl groups in 1–5 relates to k2 by lnk2 = 40.8 Eo′(Fc)–6.34. Complex 4 (IC50 = 28.2 μmol dm−3) was twice as cytotoxic as the free FcCOCH2COPh ligand having IC50 = 54.2 μmol dm−3, but approximately one order of magnitude less toxic to human HeLa neoplastic cells than cisplatin (IC50 = 2.3 μmol dm−3).